Fig. 3: Clinical Utility. | Genetics in Medicine

Fig. 3: Clinical Utility.

From: Sequencing as a first-line methodology for cystic fibrosis carrier screening

Fig. 3

Actions planned or pursued by cystic fibrosis (CF) at-risk couples (ARCs) as a result of knowing their CF risk status a, and comparison of actions planned or pursued by couples carrying variants that are included on the CF23 panel versus outside of the panel b. IVF in vitro fertilization, PGT-M preimplantation genetic testing for monogenic conditions, PNDx prenatal diagnostic testing, TOP termination of pregnancy. Asterisk (*) indicates ARCs could choose more than one action, so percentages sum to more than 100%.

Back to article page